To determine the computer predicted anti-cancer activity of an antibiotic batumin.
medicine, which has yet to be identified. Examples of unexpected therapeutic activities of various natural secondary metabolites were overviewed by Vaishnav & Demain [4] , who showed a great deal of unexplored potential of previously discovered bioactive compounds. Innovative computational tools of molecular docking and pharmacophore analysis allow prediction of therapeutic activities of natural and synthesized chemical compounds [5] . These techniques may aid in discovery of new activities of known drugs.
In this paper, discovery of the promising anti-cancer activity of the antibiotic batumin is presented. This antibiotic is produced by Pseudomonas batumici and is known as an active antibacterial agent against Staphylococcus aureus including methicillin resistant variants of this pathogen [6, 7] . Impairment of the fatty acid biosynthesis in bacteria by inhibiting the activity of the protein enoyl-ACP reductase (FabI) was suggested as a mode of action of batumin [8] .
However, computer modeling of molecular docking of batumin to FabI failed in the identification of any possible binding site for this antibiotic in the active center of FabI [9] . By contrast, a high affinity of batumin to the Rossmann fold domain of aminoacyl tRNA synthetases was predicted in this work and an alternative model of the antimicrobial action of batumin was suggested. Controversies in the proposed models were pointed out in a subsequent publication [10] . In the current study, computer based high-throughput screening was carried out against the PharmaDB database in order to address these disagreements and to identify alternative molecular targets of batumin. Surprisingly, the search did not identify any of the previously proposed molecular targets but indicated possible affinity of batumin to active centers of several cancer related proteins. Furthermore, this study demonstrated that batumin exerts cytotoxic and apoptotic activity in cancer cell lines.
Batumin is a linear polyene antibiotic encoded by a large hybrid operon of polyketide synthases and nonribosomal peptide synthetase (PKS-NRPS) comprising of 30 genes [8, 9] . Natural PKS-NRPS encoded polyene compounds are versatile in their chemical structures and biological activities [11] , which include many potential and clinically approved antibacterial, antiviral, antifungal and anti-cancer drugs [12] . Detailed stereochemical analysis of kalimatacin/batumin antibiotics has recently been published [13] . Polyene antibiotics are convenient products for genetic engineering as all their structural versatility can be designed by manipulations of a limited number of functional building units [14] . Hence, knowledge of the molecular 4 mechanisms of action of bioactive compounds will aid in design and optimization of new antibiotics.
Materials & methods

Extraction of batumin
The antibiotic batumin was obtained from culture medium of the producer-strain Pseudomonas batumici UCM B-321 as previously described [15] . The producer-strain was cultivated in a 5 l fermenter Biostat M5 (Sartorius, Germany) with automated control of growth parameters in aerobic conditions at 25°С for 65 h. Extraction of batumin was carried out from acidified culture liquid by chloroform (1:2). The extract was evaporated and purified by preparative chromatography in a 20×1.5 cm column with silicagel (Fluka, USA) with a pore size of 40-100 μm in liquid phase of benzene:acetone (1:1). Batumin yield was detected by TLC using Merck plates. All active fractions were combined and vacuum dried. Presence of batumin in the resulted substance was detected by HPLC and proton magnetic resonance (PMR) previously described [15] .
Cancer cell lines
The human epidermoid carcinoma (A431), human lung adenocarcinoma (A549) and an in vitro The MCF-7 and HeLa cell lines were maintained in Eagle's Essential Medium (EMEM). The A431, UCT-Mel 1 and HaCat cell lines were maintained in DMEM. All cell lines were supplemented with 1% antibiotics (100 µg/mL penicillin, 100 µg/mL streptomycin and 250 µg/L fungizone) and 10% heat-inactivated FBS. The cells were grown at 37°C in a humidified incubator set at 5% CO2. Cells were sub-cultured with 0.25% (w/v) trypsin 0.53 mM ethylenediaminetetraacetic acid (EDTA) for a maximum of 15 min every 2-3 days after they had formed an 80% confluent monolayer.
In vitro cytotoxicity assays
To analyze the effect of batumin on cell viability, MTT [16] and XTT [17] assays were performed. A stock solution of 10 mg/mL batumin was prepared. Serial dilutions were made to achieve target concentrations of batumin in a wide range 3.125 -400 g/mL assuming that the cytotoxic activity of batumin may be culture specific. Plates were then incubated for 24 h at 37ºC and 5% CO2 to allow cells to attach to the bottom of the wells. Subsequently, cells were exposed to batumin in dimethyl sulfoxide (DMSO) 2% medium supplemented with 2.5% FBS as described below. The control wells included vehicle-treated cells exposed to 2% DMSO; cells propagated in growth medium and cells exposed to actinomycin D [18] in a range of concentrations 0.002 -0.5 g/mL. Actinomycin D was one of the first antibiotics that was discovered to have antiproliferative-, apoptotic-and anticancer activity and it's mechanism of action ultimately also exerts an effect on p53. As such, Actinomycin D was considered as an appropriate positive standard control in this study. For the MTT assay, cells (1×10 3 cells/well) were seeded in 100 µl in 96-well microtitre plates at a concentration of 1×10 3 cells/mL and incubated with batumin for 48 h at 37ºC in a DMEM medium supplemented with 2.5% FBS. The cells were routinely treated with 3-[4,5-dimethylthiazole-2-yl]-2,5-diphenyltetrazolium bromide 6 (МТТ reagent) by the standard protocol. The colorimetric reaction was evaluated by means of an ELISA reader (Awareness Technology Inc, USA) at 545 nm wavelength with a reference wavelength 690 nm.
For the XTT assay, cells were seeded in 100 µl DMEM medium in 96-well microtitre plates at a concentration of 1×10 5 cells/mL. Plates were incubated with batumin for a further 72 h at 37ºC. Subsequently, 50 µl 3-[4,5-dimethylthiazole-2-yl]-2,5-diphenyltetrazolium bromide (XTT reagent) was added to a final concentration of 0.3 mg/mL and the plates were incubated for 2 h.
After the incubation period, the absorbance of the color complex was read at 490 nm with a reference wavelength set at 690 nm using a BIO-TEK Power-Wave XS multi-well plate reader (A.D.P, Weltevreden Park, South Africa).
In vivo study
For the in vivo study of anti-cancer activity of batumin, 13 two-month-old female C57BL mice weighing 20-22 g were obtained from the animal facility of IEPOR. All procedures were carried out according to the rules of the Ethic Committee of IEPOR and were approved by the Ethic Board of IEPOR.
Lewis lung carcinoma (3LL) cells were cultured in vitro in 50 mLl flasks with DMEM culture medium supplemented with 10% FBS, 100 units/mL penicillin, 100 μg/mL streptomycin sulphate in 5% CO2 atmosphere at 37ºC. When the cells reached confluence, they were routinely detached with 0.5% trypsin solution, washed with phosphate buffer saline (PBS), counted in a hemocytometer and used for transplantation to experimental animals. The volume of metastases was estimated by the following equation [19] :
where ni is the number of metastases with average diameters di of 0.5 mm, 1.0 mm, 1.5 mm and greater with a step of 0.5 mm.
Cell morphology
Exponentially growing cells were seeded at 2 x 10 5 cells per well in 6-well plates on heatsterilized coverslips. After 24 h of incubation at 37ºC and 5% CO2 to allow for cell adherence, cells were exposed to a range of concentrations (4.5, 9 and 12 µg/mL) of batumin. Cells propagated in growth medium and vehicle-treated (1% DMSO) cells were included as controls.
Subsequently, cells were incubated at 37°C for a period of 72 h. Following the incubation period, the media was discarded and the cells were washed with PBS. The cells were stained with the  
standard hematoxylin and eosin staining procedure as previously described [20] . Microscopy slides were prepared and the cells were observed under a light microscope (ZEISS, Primovert) at 40X magnification.
Cell cycle progression
Flow cytometry and propidium iodide were utilized to investigate the DNA content in order to determine the influence of batumin on the cell cycle progression and possible apoptosis induction. Propidium iodide stains the DNA and thus enables the quantification of DNA correlating with stages of the cell cycle during cell division [21] . Cells were plated at 500,000 cells per 25 cm 2 flask and left for 24 h to attach. Subsequently, cells were exposed to batumin for 72 h at 37°C. Cells propagated in growth medium and vehicle-treated cells were included as negative controls and cells treated with actinomycin D were included as a positive control of apoptosis induction. After exposure to batumin, cells were trypsinized in 0.25% (w/v) trypsin with 0.53mM EDTA for approximately 15 min or till cells are rounded and ready to detach from the flask surface. Then 10 6 cells were centrifuged for 5 min at 300 x g. The pellet was resuspended twice in ice-cold PBS. The supernatant was discarded and cells were resuspended in 200 µl of ice-cold PBS containing 0.1% FBS. Ice-cold 70% ethanol (4 mL) was added in a dropwise manner and cells were stored at 4ºC for 24 h. Cells were pelleted by centrifugation for 5 min. The supernatant was removed and cells were resuspended in 1 mL of PBS containing propidium iodide (40 µg/mL), 0.1% triton X-100 and RNase A (100 μg/mL), and incubated at 37ºC in 5% CO2 for 45 min. Cells were analysed by means of a FC500 flow cytometer Beckman Coulter (Brea, CA, USA). Data from cell debris (particles smaller than apoptotic bodies) and clumps of 2 or more cells were removed from further analysis. Cell cycle distributions were calculated by Cyflogic version 1.2.1 (Pertu Therho, Turko, Finland), which assigns relative DNA content per cell to sub-G1, G1, S and G2/M phases.
In silico molecular docking
The chemical structure of batumin has been described in previous publications [6, 8, 9] . Accelrys Discovery Studio 4.0 was used to generate a collection of 94 spatial conformations of batumin, which were then used for querying the PharmaDB database that contains more than 140,000 pharmacophore models [22] . Thereafter, the molecular docking of batumin molecules was performed against identified target proteins by using the LibDock algorithm [23] . Electronic structures of the target proteins in PDB format with identified binding sites and chemical structures of known inhibitors were obtained from RCSB PDB database (www.rcsb.org, [24] ).
Statistical analysis
Statistical analysis of the results was performed by the descriptive statistics, Student's t-test and Mann-Whitney U test, with the use of Microsoft Excel and Microcal Origin programs. All assays were performed a minimum of three times. The fifty percent inhibitory concentration (IC50) of the compound was calculated using the GraphPad Prism 4 program (GraphPad Software, Inc., CA, USA). The safety margin of the compound was also taken into account by calculating the selectivity index (SI) values as a ratio of IC50 determined on non-cancerous cells to IC50 cancerous cell line. The SI value gives an indication of the specificity towards either the cancerous cell line or the non-cancerous cell line [25] . An SI value greater than one indicates a specificity towards the cancerous cell line; whereas an SI value less than one implies that the compound is more toxic towards the non-cancerous cell line. The SI value of the compound was calculated as the ratio of the IC50 value on a non-cancerous cell line to the IC50 value on a cancerous cell line.
Flow cytometry analysis involved at least 10,000 events and was repeated three times, where the mean and the standard deviation were calculated. Flow cytometry data was analyzed using Cyflogic version 1.2.1 (Perko, Finland). P-values less than 0.05 were regarded as statistically significant.
Results
Search through PharmaDB and molecular docking
Batumin has been previously identified as an anti-staphylococcal antibiotic [7] . However, the search through PharmaDB revealed a possible affinity of batumin to active centers of cancer related proteins p53 and Act1. Anticancer activity of batumin has never been reported before. In previous studies, it was suggested that batumin could suppress the growth of Staphylococcus aureus by binding to protein FabI and impairing fatty acid biosynthesis in bacteria [8] . However, another study determined by molecular docking that batumin had no affinity to FabI, but it could bind to the Rossmann fold domain of aminoacyl tRNA synthetases similar to the antibiotic mupirocin [9] . This hypothesis was criticized in a subsequent paper [10] . This paper reported that in contrast to mupirocin, which resulted in a strong inhibition of the protein biosynthesis in S. aureus in 10 min after treatment, batumin suppressed mainly fatty acid biosynthesis resembling the activity of triclosana FabI inhibitor. Surprisingly, the search through the PharmaDB returned neither FabI, nor tRNA synthetases as possible targets of batumin which caused doubts regarding the accuracy of the pharmacophore approach of identification of possible molecular targets. Nonetheless, due to the importance of discovering new anti-cancer drugs, it was decided to continue studying the possible anti-cancer activity of batumin by molecular docking to the predicted molecular targets and by the evaluation of the cytotoxicity of batumin on cancer cell lines.
A possible affinity for batumin was predicted against the mouse double minute 2 homolog (MDM2) active center of p53, which is responsible for an inhibition of p53 apoptosis activity.
Blocking this center by ligands potentially restores apoptosis in cancer cells [26] . The molecular structure of MDM2 was obtained from the RCSB PDB database [24] (accessions IDs 4QO3 and 4OQ4). X-Ray proved locations of several MDM2 inhibitors in the active center of the protein, which were provided in the database [27, 28] . The molecular structures of these inhibitors were (Table 1) . A similar estimation of a binding energy of 53.1 kcal/mol was obtained by docking the batumin chemical structure against the active center of the protein Act1 (DCSB ID 4GV1, [29] ).
Cytotoxicity assays
Preliminary assays for the anti-cancer activity of batumin were performed independently in two laboratories at the University of Pretoria (UP) in South Africa by XTT approach [17] and at IEPOR by MTT approach [16] . To ensure unbiasedness of results to laboratory specific conditions and cell cultures, the experiments on cytotoxicity were performed in both institutes in parallel using own protocols and cell cultures without any exchange of results until the experiments were finished. At UP, batumin was tested in several cell lines in concentrations of 3.125, 6.25, 12.5, 25, 50, 100, 200 and 400 g/mL (Fig. 1 ). This rather wide range of concentrations was applied due to absence of any preliminary data on sensitivity of cancer cells to batumin and because of an assumption that the toxicity of batumin may be culture specific.
The dose dependent effect of batumin was observed with the highest activity against the UCT-Mel 1 melanoma cell line (IC50 = 4.5 g/mL). By contrast, batumin showed no activity against the normal skin keratinocytes (HaCat) at concentrations up to 100 g/mL. Table 2 shows IC50 and SI values calculated for batumin based on the cytotoxicity data in Fig. 1 in comparison to the activity of actinomycin D used in this study as a positive control. Batumin in average was 3 to 4 order of magnitude less active than actinomycin D, but in contrast to the latter antibiotic, the 13 activity of batumin was strongly culture specific. As it is evident from SI values, the melanoma skin cancer cell line was 20-fold more sensitive to batumin than the other cancer cell lines evaluated in this assay and the normal keratinocytes. The cytotoxicity of batumin was evaluated at IEPOR in the human epidermoid carcinoma (A431) and human lung adenocarcinoma (A549) cell lines. A dose dependent effect of batumin was observed in both cancer cell lines (Fig. 2) with an IC50 around 20-25 μg/mL for A431 and 5-10 μg/mL for A549 cells. For experiments conducted at IEPOR, batumin was almost 8 times more toxic against A431 cells than in the experiment on the same cell line at UP. It may reflect either the different load of cancer cells used in these two laboratories -5×10 5 for XTT at UP and 5×10 3 for MTT at IEPOR. Batumin showed almost the same strong toxicity against A549 cells in the MTT assay as against melanoma cells (UCT-Mel 1) in parallel experiments at UP ( Fig. 1 and   14 Table 2) in the XTT assay; however, the cell load in the XTT assay was two order of magnitude higher. 
Melanoma cell morphology
Light microscopy was conducted to assess the effect of batumin on the morphology of UCT-Mel 1 melanoma cells. Generally, different types of tissues stained by haematoxylin and eosin display nuclei that are blue to purple in color, whereas the cytoplasm and extracellular matrix display varying pink color shades. Different types of cell death can be distinguished from one another by specific morphological characteristics, which include the loss of plasma membrane integrity, fragmentation of cells and nucleus into apoptotic bodies and engulfment of remaining fragments of one cell by another [30] .
Morphological characteristics of apoptotic cell death, such as hypercondensed chromatin and apoptotic body formation were observed at a lower concentration of batumin (Fig. 3A ).
Furthermore, exposure to higher concentrations of batumin (6 and 12 µg/mL) resulted in a prevalence of vesicle formation, which could be an indicative of autophagy induction (Fig. 3B-C ). UCT-Mel 1 samples treated with a vehicle control (1% DMSO) had a higher cell density than the cells treated with higher concentrations of batumin. Normal cell division process was observed in the control cells that was almost absent in the treated cells (Fig. 3D ). 
Cell cycle progression
The effect of batumin on cell cycle progression was investigated by means of flow cytometry.
Exposure to batumin induced a statistically significant increase in the quantity of cells occupying the sub-G1 phase suggesting induction of apoptosis ( Fig. 4 and Table 4 ). Exposure to batumin resulted in a statistically significant increase in the number of HaCat cells occupying the sub-G1 
Anti-metastatic activity of batumin
The in vitro study indicated that human lung adenocarcinoma cells were sensitive to batumin ( Fig. 2) . Therefore, we performed a pilot study of anticancer activity of batumin using Lewis injections (350 μg of batumin in 0.5 mL physiologic solution per mouse per injection). Primary tumor growth dynamics was monitored daily starting from day 7 after 3LL transplantation until the end of the experiment on day 23. In this experiment, we relied on earlier done assessment of batumin toxicity in vivo, and did not perform the toxicity study. Visually, the control and experimental animals presented no differences in behaviour and weight (data not shown).
Administration of batumin at metronomic regimen significantly reduced the number and total volume of metastases in mice. The number of lung metastases was reduced by two-fold in the batumin treated animals when compared to the control group resulting in a statistically significant difference with P < 0.05. The total volume of metastases was nearly 10 times lower in the batumin treated animals as compared to the control group (P < 0.05). However, 14% of the inhibitory effect of batumin on primary tumor growth was below the statistical reliability with P > 0.05 (Table 3 ). Thus, it was concluded that the administration of batumin at a metronomic regimen caused a significant anti-metastatic effect in 3LL-bearing animals.
Conclusion
Batumin has been used in the composition of an experimental 0.1% batumin ointment for the treatment and prevention of S. aureus nasal carriage at concentrations, which have been shown in this work to be therapeutic against melanoma cells [34] . No significant side effects of the ointment application have been reported. This work demonstrates an unexpected anti-cancer activity of batumin, which was known before as an antibiotic against S. aureus. This activity was predicted by in silico screening against the PharmaDB database of pharmacophores for possible binding sites of this antibiotic. Predicted affinity to the active centers of two cancer related proteins was confirmed by molecular docking modeling and in experimental trials conducted in two independent laboratories using different approaches of cytotoxicity trials.
Computational modeling suggests that batumin may induce apoptosis in several types of cancer cells by binding to the MDM2 active center of the p53 transcriptional regulator which prevents inhibition of this protein in cancer cells [26] . Cell cycle progression studies suggested that batumin may induce apoptosis since an increase in the percentage of cells occupying the phase sub-G1 was observed. This hypothesis was supported by light microscopic study of morphological changes in batumin treated cells. Induction of apoptosis by batumin has not been reported before. Although this effect was observed for both melanoma cells and normal skin keratinocytes, possible apoptosis induction by batumin was more prominent in the melanoma cells. This observation may explain the observed difference in the cytotoxicity of batumin on UCT-Mel 1 and HaCat cells ( Fig. 1 and Table 2 ). Furthermore, it was demonstrated that the cell line specific toxicity of batumin had the highest activity against melanoma and lung carcinoma cells, with moderate to no toxicity against other tested cancer cells and normal skin keratinocytes. The potential of batumin as a possible anti-cancer drug was further supported by the results of the in vivo experiment on mice transplanted with 3LL cells. While the primary tumor remained basically unaffected, injections of batumin significantly reduced the number and total volume of metastases in experimental mice. Potential anticancer activity of polyene antibiotics and their ability to potentiate significantly the effect of other antibiotics has been reported previously. However, the extreme versatility of these natural compounds did not allow identification of any structural element correlated with observed antibacterial and/or anticancer activities [31] . Strongly specific cytotoxicity against several melanoma cell lines was reported for a polyene marinomycins synthesized by marine actinomycetes [32] . However, the structure of these circular macrodiolide antibiotics is not similar to the structure of batumin to be able to speculate about any commonality of the mechanisms of their cytotoxicity.
Future perspective
This study demonstrated culture specific toxicity of batumin against melanoma and lung carcinoma cells. Light microscopy and cell cycle progression results suggest the induction of apoptosis as a possible type of cell death. In vitro data obtained from this study warrants future research on assessing batumin's potential as antiproliferative agent and its involvement in the extrinsic-and extrinsic pathway of apoptosis by caspase dependent-or independent pathways to unravel its mechanism of action in cell death and the prospects of its application as an anticancer agent [33] . Additional studies to assess the potential anti-proliferative effect of batumin and prospects of its application as an anticancer agent should be conducted also. The most striking was the result that melanoma cells were 20 fold more sensitive to batumin than the normal keratinocytes. High toxicity of anti-cancer drugs is one of the major problems of chemotherapy. 20 Consider, for example, the cytotoxicity of actinomycin D in Table 2 . It looks prospective to use batumin as a model to study culture specific mechanisms of cytotoxicity for future design of effective non-toxic anti-cancer drugs.
Executive summary
 Batumin was laboratory extracted for this study from the culture medium of Pseudomonas batumici.
 Batumin significantly inhibits the growth of UCT-Mel 1 melanoma and A549 human lung adenocarcinoma cell lines.
 Batumin showed low toxicity against HaCat skin keratinocytes that was 20 fold lower than that detected for melanoma cells. 
